Skip to main content
. 2020 Oct 11;9(10):3244. doi: 10.3390/jcm9103244

Table 2.

Socio-demographic data for participant dyads (n = 19).

Caregivers (n = 17) *
N (%)
Patients (n = 19)
N (%)
Age (years)
40–49 1 (5.9%) 1 (5.3%)
50–59 4 (23.5%) 2 (10.5%)
60–69 9 (52.9%) 11 (57.9%)
≥70 3 (17.7%) 5 (26.3%)
Mean 62.3 64.7
SD 6.62 7.22
Median 63 66
Language
English 15 (88.2%) 16 (18.2%)
French 1 (5.9%) 1 (5.3%)
Other 1 (5.9%) 2 (10.5%)
Education
High School 2 (11.8%) 1 (5.3%)
Post-secondary diploma 4 (23.5%) 7 (36.8%)
Undergraduate degree 11 (64.7%) 6 (31.6%)
Master’s Degree 0 (0%) 3 (15.8%)
Doctorate Degree 0 (0%) 2 (10.5%)
Health Conditions
Arthritis 6 (35.3%) 6 (31.6%)
Diabetes 2 (11.8%) 7 (36.8%)
Emotional problems 5 (29.4%) 5 (26.4%)
Hypertension 4 (23.5%) 9 (47.4%)
Heart Problems 1 (5.9%) 5 (26.4%)
Intestinal polyps 1 (5.9%) 3 (15.8%)
Liver disease 1 (5.9%) 2 (10.5%)
Sleep Apnea 1 (5.9%) 5 (26.4%)
Stomach problems 2 (11.8%) 3 (15.8%)
Thyroid 2 (11.8%) 3 (15.8%)
Household Income (n = 19 dyads)
USD 40,000 to USD 59,999 3 (15.8%)
USD 60,000 to USD 79,999 1 (5.3%)
USD 80,000 to USD 99,999 4 (21.0%)
≥ USD 100,000 7 (36.8%)
Prefer not to answer 4 (21.0%)
Marital Status (n = 19 dyads)
Single 1 (5.3%)
Married 17 (89.4%)
Common Law 1 (5.3%)
Patient Cancer Characteristics
Years since prostate cancer diagnosis
<1 year 4 (21.0%)
1–3 years 10 (52.6%)
3–5 years 5 (26.4%)
Stage of Cancer at diagnosis
Early Stage 11 (57.9%)
Advanced Stage 6 (31.6%)
Unknown 2 (10.5%)
Cancer treatments receiving, received, or plan to receive
Surgery 12 (63.2%)
Chemotherapy 4 (21.0%)
Radiotherapy 10 (52.6%)
Hormone Treatment 7 (36.8%)
Brachytherapy 2 (10.5%)
Watchful waiting 2 (10.5%)
Other 1 (5.3%)

* Caregiver data only available for 17/19 dyads. One patient was interviewed alone (e.g., his caregiver participated in TEMPO but not in the interviews), while the remaining CG data is missing.